Pharmaceutical Technology· GlobalData Healthcare·· 20 天前AI 评分18
IDWeek 2026:LB6V 未达主要终点,但在莱姆病中显示潜力
IDWeek 2026: despite missing primary endpoint, LB6V shows promise in Lyme disease
AI 导读
IDWeek 2026 数据显示,LB6V 在莱姆病中未达到主要终点,但仍显示出潜力。
来源:Pharmaceutical Technology · pharmaceutical-technology.com